Matthew Harrison
Stock Analyst at Morgan Stanley
(3.39)
# 987
Out of 5,008 analysts
700
Total ratings
48.36%
Success rate
3.45%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $766 → $1,040 | $797.35 | +30.43% | 26 | Oct 1, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $14.90 | +101.34% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $162.32 | -22.38% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $31.41 | +164.25% | 13 | Aug 12, 2025 | |
| IOBT IO Biotech | Maintains: Overweight | $6 → $4 | $0.51 | +677.30% | 6 | Aug 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $460 → $439 | $410.28 | +7.00% | 41 | Aug 5, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $754 → $761 | $583.24 | +30.48% | 55 | Aug 4, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $146 → $144 | $152.21 | -5.39% | 54 | Aug 1, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Equal-Weight | $15 → $20 | $23.12 | -13.49% | 38 | Jul 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $97 → $96 | $54.70 | +75.50% | 22 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $185.73 | +15.76% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $116.78 | +15.60% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $2.97 | +102.02% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $39 → $32 | $27.34 | +17.04% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.77 | +182.49% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $155.33 | +14.59% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $31.97 | +75.16% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $30.60 | +79.74% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $3.07 | -2.28% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $23.12 | -52.42% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.55 | +416.13% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $3.93 | +78.12% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $22.44 | +51.52% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $32.64 | -1.96% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $5.87 | +223.68% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.63 | -38.65% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $17.20 | -41.86% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $9.24 | -13.42% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $34.93 | +25.97% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.12 | +215.53% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $17.41 | +359.51% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $6.20 | +867.74% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $106.06 | +103.66% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.31 | +16.01% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.99 | +151.26% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $232.83 | -21.83% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $14.23 | -36.75% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $46.00 | -13.04% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $295.54 | -4.58% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $459.58 | -54.31% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $26.27 | +97.94% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $188.89 | -8.41% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $29.74 | +303.50% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $15.02 | +885.35% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $87.61 | -6.40% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $44.66 | +47.78% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.72 | +726.27% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $36.10 | +27.42% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $10.60 | +230.19% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $843.63 | -67.40% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.52 | +653.97% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $10.51 | +489.91% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.76 | +2.92% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $87.17 | -4.78% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $60.17 | -83.38% | 4 | Sep 10, 2018 |
argenx SE
Oct 1, 2025
Maintains: Overweight
Price Target: $766 → $1,040
Current: $797.35
Upside: +30.43%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $14.90
Upside: +101.34%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $162.32
Upside: -22.38%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $31.41
Upside: +164.25%
IO Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.51
Upside: +677.30%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $410.28
Upside: +7.00%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Overweight
Price Target: $754 → $761
Current: $583.24
Upside: +30.48%
Biogen
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $146 → $144
Current: $152.21
Upside: -5.39%
Sarepta Therapeutics
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $23.12
Upside: -13.49%
BioMarin Pharmaceutical
Jul 22, 2025
Maintains: Overweight
Price Target: $97 → $96
Current: $54.70
Upside: +75.50%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $185.73
Upside: +15.76%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $116.78
Upside: +15.60%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $2.97
Upside: +102.02%
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $27.34
Upside: +17.04%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.77
Upside: +182.49%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $155.33
Upside: +14.59%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $31.97
Upside: +75.16%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $30.60
Upside: +79.74%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $3.07
Upside: -2.28%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $23.12
Upside: -52.42%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.55
Upside: +416.13%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $3.93
Upside: +78.12%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $22.44
Upside: +51.52%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $32.64
Upside: -1.96%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $5.87
Upside: +223.68%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.63
Upside: -38.65%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $17.20
Upside: -41.86%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $9.24
Upside: -13.42%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $34.93
Upside: +25.97%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.12
Upside: +215.53%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $17.41
Upside: +359.51%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $6.20
Upside: +867.74%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $106.06
Upside: +103.66%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.31
Upside: +16.01%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.99
Upside: +151.26%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $232.83
Upside: -21.83%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $14.23
Upside: -36.75%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $46.00
Upside: -13.04%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $295.54
Upside: -4.58%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $459.58
Upside: -54.31%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $26.27
Upside: +97.94%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $188.89
Upside: -8.41%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $29.74
Upside: +303.50%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $15.02
Upside: +885.35%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $87.61
Upside: -6.40%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $44.66
Upside: +47.78%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.72
Upside: +726.27%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $36.10
Upside: +27.42%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $10.60
Upside: +230.19%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $843.63
Upside: -67.40%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.52
Upside: +653.97%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $10.51
Upside: +489.91%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.76
Upside: +2.92%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $87.17
Upside: -4.78%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $60.17
Upside: -83.38%